Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
976 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05132998 | Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors | completed | N/A | 80 | Associacao de Investigacao de Cuidados de Suporte em OncologiaOTHER | 1 | Oct 4, 2022 | clinicaltrials |
| NCT02913729 | Pre- Versus Postoperative Accelerated Partial Breast Irradiation(PAPBI-2) | terminated | N/A | 65 | The Netherlands Cancer InstituteOTHER | 4 | Sep 29, 2022 |
| clinicaltrials |
| NCT03410693 | Study of Rogaratinib (BAY1163877) vs Chemotherapy in Patients With FGFR (Fibroblast Growth Factor Receptor)-Positive Locally Advanced or Metastatic Urothelial Carcinoma(FORT-1) | completed | Phase 2 / Phase 3 | 175 | BayerINDUSTRY | 29 | Sep 28, 2022 | clinicaltrials |
| NCT04937777 | A Study on the Management and Outcome of Patients With Systemic AL Amyloidosis in Europe | completed | — | 4,481 | European Myeloma Network B.V.NETWORK | 10 | Sep 27, 2022 | clinicaltrials |
| NCT04389086 | Induction Chemotherapy for Locally Recurrent Rectal Cancer(PelvEx II) | recruiting | Phase 3 | 364 | Catharina Ziekenhuis EindhovenOTHER | 5 | Sep 6, 2022 | clinicaltrials |
| NCT05111795 | Holmium-166 Retrospective Collection of Real-World Data(RECORD) | completed | — | 146 | Terumo Europe N.V.INDUSTRY | 7 | Aug 30, 2022 | clinicaltrials |
| NCT04502394 | Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL | recruiting | Phase 1 / Phase 2 | 84 | Kartos Therapeutics, Inc.INDUSTRY | 11 | Aug 4, 2022 | clinicaltrials |
| NCT02162667 | Efficacy and Safety Evaluating Study of CT-P6 in Her2 Positive Early Breast Cancer | completed | Phase 3 | 562 | CelltrionINDUSTRY | 22 | Aug 3, 2022 | clinicaltrials |
| NCT03442985 | An Efficacy and Safety Study of Palovarotene for the Treatment of MO(MO-Ped) | terminated | Phase 2 | 193 | Clementia Pharmaceuticals Inc.INDUSTRY | 12 | Aug 1, 2022 | clinicaltrials |
| NCT04756635 | Effects of Short- Term Intermittent Fasting Aerobic and Anaerobic Capacity(Performance) | unknown | N/A | 50 | Faculdade de Motricidade HumanaOTHER | 1 | Jul 26, 2022 | clinicaltrials |
| NCT05473052 | Home-based Exercise Training for Lung Cancer Patients Awaiting Surgery | completed | N/A | 15 | Instituto Politécnico de LeiriaOTHER | 1 | Jul 25, 2022 | clinicaltrials |
| NCT02340221 | A Study of Taselisib + Fulvestrant Versus Placebo + Fulvestrant in Participants With Advanced or Metastatic Breast Cancer Who Have Disease Recurrence or Progression During or After Aromatase Inhibitor Therapy(SANDPIPER) | terminated | Phase 3 | 631 | Hoffmann-La RocheINDUSTRY | 28 | Jul 12, 2022 | clinicaltrials |
| NCT01723969 | Screening Platform for Clinical Trials in Advanced Colorectal Cancer(SPECTAcolor) | completed | — | 668 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 11 | Jul 7, 2022 | clinicaltrials |
| NCT02692339 | Safety Study of Lenalidomide/Dexamethasone to Treat Patients With Relapsed or Refractory Multiple Myeloma(PrObe-L) | completed | — | 22 | CelgeneINDUSTRY | 1 | Jun 30, 2022 | clinicaltrials |
| NCT02200614 | Efficacy and Safety Study of Darolutamide (ODM-201) in Men With High-risk Non-metastatic Castration-resistant Prostate Cancer(ARAMIS) | completed | Phase 3 | 1,509 | BayerINDUSTRY | 36 | Jun 28, 2022 | clinicaltrials |
| NCT00976911 | AURELIA: A Study of Avastin (Bevacizumab) Added to Chemotherapy in Patients With Platinum-resistant Ovarian Cancer | completed | Phase 3 | 361 | Hoffmann-La RocheINDUSTRY | 14 | Jun 21, 2022 | clinicaltrials |
| NCT04499833 | HepatoPredict Prognostic Tool for the Decision of Liver Transplant in Hepatocellular Carcinoma(HepatoPredict) | recruiting | N/A | 40 | Centro Hospitalar de Lisboa CentralOTHER | 1 | Jun 6, 2022 | clinicaltrials |
| NCT05174845 | Real Word Evidence With 1L Polyethylene Glycol (PEG)+ Ascorbic Acid in Iberia | completed | — | 13,393 | NorgineINDUSTRY | 2 | May 31, 2022 | clinicaltrials |
| NCT02999854 | Safety and Efficacy of ATIR101 as Adjunctive Treatment to Blood Stem Cell Transplantation From a Haploidentical Family Donor Compared to Post-transplant Cyclophosphamide in Patients With Blood Cancer(HATCY) | terminated | Phase 3 | 63 | Kiadis PharmaINDUSTRY | 13 | May 24, 2022 | clinicaltrials |
| NCT03323489 | Celiac Plexus Radio-Surgery for Pain Management | completed | N/A | 125 | Dr. Yaacov LawrenceOTHER_GOV | 4 | May 12, 2022 | clinicaltrials |
| NCT01578239 | A Study Comparing Treatment With 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR in Patients With Inoperable, Progressive, Somatostatin Receptor Positive Midgut Carcinoid Tumours(NETTER-1) | completed | Phase 3 | 231 | Advanced Accelerator ApplicationsINDUSTRY | 8 | Apr 4, 2022 | clinicaltrials |
| NCT01702571 | A Study of Trastuzumab Emtansine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer Who Have Received Prior Anti-HER2 And Chemotherapy-based Treatment | completed | Phase 3 | 2,185 | Hoffmann-La RocheINDUSTRY | 43 | Apr 4, 2022 | clinicaltrials |
| NCT02335957 | OPTimizing Irradiation Through Molecular Assessment of Lymph Node (OPTIMAL)(OPTIMAL) | completed | N/A | 489 | Grupo de Investigación Clínica en Oncología RadioterapiaOTHER | 3 | Apr 1, 2022 | clinicaltrials |
| NCT04613570 | SUrveillance of PREMalignant Stomach - Individualized Endoscopic Follow-up(SUPREME) | recruiting | N/A | 912 | Instituto Portugues de Oncologia, Francisco Gentil, PortoOTHER | 1 | Mar 31, 2022 | clinicaltrials |
| NCT04085042 | Impact of a Multimodal Intervention on Peripheral Venous Catheterization of Cancer Patients(MultiCat) | completed | N/A | 200 | Escola Superior de Enfermagem de CoimbraOTHER | 1 | Mar 23, 2022 | clinicaltrials |
| NCT05246891 | Rehabilitation Nursing Program in Otolaryngology | completed | — | 151 | University of ÉvoraOTHER | 1 | Mar 7, 2022 | clinicaltrials |
| NCT05267392 | Neoadjuvant Immunotherapy With Durvalumab (MEDI4736) in Non-Surgical Early Stage or Locally Advanced Non-Small Cell Lung Cancer (NSCLC) Followed by Radical Radiotherapy or Chemoradiotherapy(IDEAR) | unknown | Phase 1 / Phase 2 | 30 | Instituto Portugues de Oncologia, Francisco Gentil, PortoOTHER | 1 | Mar 4, 2022 | clinicaltrials |
| NCT05071560 | Physical Exercise for Breast Cancer Survivors: Face-to-face Versus Home-based(On4Rehab) | completed | N/A | 12 | Associacao de Investigacao de Cuidados de Suporte em OncologiaOTHER | 1 | Mar 2, 2022 | clinicaltrials |
| NCT03794544 | Neoadjuvant Durvalumab Alone or in Combination With Novel Agents in Resectable Non-Small Cell Lung Cancer | completed | Phase 2 | 84 | MedImmune LLCINDUSTRY | 7 | Feb 24, 2022 | clinicaltrials |
| NCT04024280 | Effects of a Physical Exercise Program in Quality of Life of Breast Cancer Survivors(MamaMoveGaia) | completed | N/A | 80 | Associacao de Investigacao de Cuidados de Suporte em OncologiaOTHER | 1 | Feb 16, 2022 | clinicaltrials |
| NCT00322218 | Study Comparing Zevalin Regimen With no Further Treatment in Patients With Diffuse Large B-cell Lymphoma. | terminated | Phase 3 | 68 | Spectrum Pharmaceuticals, IncINDUSTRY | 19 | Jan 19, 2022 | clinicaltrials |
| NCT05193006 | Assessment of Histologic Prognostic Factors in Peritoneal Malignant Mesothelioma | unknown | — | 300 | Hospices Civils de LyonOTHER | 6 | Jan 14, 2022 | clinicaltrials |
| NCT00982111 | First-line Treatment of Patients With Stage IV Nonsquamous Non-Small Cell Lung Cancer With Necitumumab (IMC-11F8) and Pemetrexed-Cisplatin(INSPIRE) | completed | Phase 3 | 633 | Eli Lilly and CompanyINDUSTRY | 20 | Jan 11, 2022 | clinicaltrials |
| NCT01712789 | Evaluation of Safety of Pomalidomide in Combination With Dexamethasone (Low Dose) in Patients With Refractory or Relapsed and Refractory Multiple Myeloma(STRATUS) | completed | Phase 3 | 682 | CelgeneINDUSTRY | 20 | Jan 10, 2022 | clinicaltrials |
| NCT02136069 | A Study Comparing the Efficacy and Safety of Etrolizumab to Infliximab in Participants With Moderate to Severe Ulcerative Colitis Who Are Naïve to Tumor Necrosis Factor (TNF) Inhibitors(GARDENIA) | completed | Phase 3 | 397 | Hoffmann-La RocheINDUSTRY | 20 | Dec 3, 2021 | clinicaltrials |
| NCT03568929 | Safety Profile of Idelalisib in Patients With Refractory Follicular Lymphoma(ZEUS) | completed | — | 257 | Gilead SciencesINDUSTRY | 10 | Nov 19, 2021 | clinicaltrials |
| NCT01596114 | European Stop Tyrosine Kinase Inhibitor Study(EURO-SKI) | completed | Phase 3 | 868 | European LeukemiaNetNETWORK | 10 | Nov 5, 2021 | clinicaltrials |
| NCT05100446 | Comparison Between High-dose Amoxicillin Dual Therapy and Pylera Quadruple Therapy in the Treatment of Helicobacter Pylori Infection | unknown | Early Phase 1 | 100 | Unidade Local de Saúde do Alto Ave, EPEOTHER | 1 | Oct 29, 2021 | clinicaltrials |
| NCT02566993 | Clinical Trial of Lurbinectedin (PM01183)/Doxorubicin Versus CAV or Topotecan as Treatment in Patients With Small-Cell Lung Cancer(ATLANTIS) | completed | Phase 3 | 613 | PharmaMarINDUSTRY | 20 | Oct 28, 2021 | clinicaltrials |
| NCT00975676 | Study of Estrogen Levels in Premenopausal Women Who Have Undergone Surgery for Breast Cancer and Are Receiving Triptorelin and Tamoxifen Citrate or Exemestane on Clinical Trial IBCSG 24-02(SOFT-EST) | completed | N/A | 123 | ETOP IBCSG Partners FoundationNETWORK | 8 | Oct 25, 2021 | clinicaltrials |
| NCT00078832 | Anastrozole in Preventing Breast Cancer in Postmenopausal Women at Increased Risk of Breast Cancer(IBIS II) | completed | Phase 3 | 3,864 | Queen Mary University of LondonOTHER | 14 | Oct 6, 2021 | clinicaltrials |
| NCT01077154 | Study of Denosumab as Adjuvant Treatment for Women With High Risk Early Breast Cancer Receiving Neoadjuvant or Adjuvant Therapy (D-CARE) | terminated | Phase 3 | 4,509 | AmgenINDUSTRY | 39 | Sep 28, 2021 | clinicaltrials |
| NCT02366143 | A Study of Atezolizumab in Combination With Carboplatin Plus (+) Paclitaxel With or Without Bevacizumab Compared With Carboplatin+Paclitaxel+Bevacizumab in Participants With Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC)(IMpower150) | completed | Phase 3 | 1,202 | Hoffmann-La RocheINDUSTRY | 26 | Sep 23, 2021 | clinicaltrials |
| NCT04996147 | Acute and Long-term Impact of Cancer Treatment on Head and Neck Cancer Patients: FIT4TREATMENT(F4T) | terminated | — | 21 | Associacao de Investigacao de Cuidados de Suporte em OncologiaOTHER | 1 | Aug 9, 2021 | clinicaltrials |
| NCT03585218 | Women With Breast Cancer Undergoing Chemotherapy: Implications in Quality of Life | completed | N/A | 112 | University of MinhoOTHER | 1 | Aug 5, 2021 | clinicaltrials |
| NCT03033511 | A Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First- Line Platinum-Based Chemotherapy in Participants With Extensive Stage Small Cell Lung Cancer (MERU)(MERU) | terminated | Phase 3 | 748 | AbbVieINDUSTRY | 41 | Jul 29, 2021 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials